Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)

Enferm Infecc Microbiol Clin. 2015 Dec;33(10):679.e1-679.e21. doi: 10.1016/j.eimc.2015.03.024. Epub 2015 May 12.

Abstract

Background: Urinary tract infections (UTIs) are one of the most common infections in solid organ transplant (SOT) recipients.

Methods: Experienced SOT researchers and clinicians have developed and implemented this consensus document in support of the optimal management of these patients. A systematic review was conducted, and evidence levels based on the available literature are given for each recommendation. This article was written in accordance with international recommendations on consensus statements and the recommendations of the Appraisal of Guidelines for Research and Evaluation II (AGREE II).

Results: Recommendations are provided on the management of asymptomatic bacteriuria, and prophylaxis and treatment of UTI in SOT recipients. The diagnostic-therapeutic management of recurrent UTI and the role of infection in kidney graft rejection or dysfunction are reviewed. Finally, recommendations on antimicrobials and immunosuppressant interactions are also included.

Conclusions: The latest scientific information on UTI in SOT is incorporated in this consensus document.

Keywords: Consenso; Consensus; Infección urinaria; Profilaxis; Prophylaxis; Transplantation; Trasplante; Tratamiento; Treatment; Urinary infection.

Publication types

  • Consensus Development Conference
  • Practice Guideline
  • Systematic Review

MeSH terms

  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use
  • Antibiotic Prophylaxis
  • Asymptomatic Diseases
  • Bacteriuria / drug therapy
  • Drug Interactions
  • Female
  • Graft Rejection
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Organ Transplantation
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / etiology
  • Postoperative Complications / microbiology
  • Prostatitis / drug therapy
  • Prostatitis / etiology
  • Recurrence
  • Risk Factors
  • Transplant Recipients*
  • Urinary Tract Infections / drug therapy*
  • Urinary Tract Infections / epidemiology
  • Urinary Tract Infections / etiology
  • Urinary Tract Infections / microbiology

Substances

  • Anti-Infective Agents
  • Immunosuppressive Agents